AzTrials
AzTrials

Knee OsteoarthritisNCT04046003

Tai Chi for Knee OA Pain Management: a Mechanistic Study

A study testing Tai chi exercise in people with Knee Osteoarthritis and Mind-body Exercise, run by Texas Tech University Health Sciences Center at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study is to determine how 8-week Tai Chi intervention alters plasma endocannabinoid and its receptors in monocytes/marcrophages, plasma oxylipinds, plasma brain-derived neurotrophic factor, brain white matter connectivity/efficiency, and functional/clinical outcomes in women with knee OA. Read more about this study

Who is it for?
Any age, women only
Conditions the study is for
Knee Osteoarthritis, Mind-body Exercise
What is being tested?
Tai chi exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
33 participants
Where
1 siteUnited States
Study dates
1 Sep 2019to 31 Aug 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Women only
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Postmenopausal women.
  • WOMAC pain score ≥ 50 on at least 1 of the 5 questions in pain subscale (range of 0 to 100, with higher scores indicating greater pain.
  • English literacy.
  • Able to undergo an MRI scan
  • Diagnosed Have the following symptoms associated with knee OA based on American College of Rheumatology clinical classification criteria for osteoarthritis (Peat 2006). Pain in the knee. Need to at least 3 of the following: over 50 years of age, less than 30 minutes of morning stiffness, crepitus on active motion, bony tenderness, bony enlargement, or no palpable warmth of synovium.

Who cannot join

  • Prior experience with mind-body practice (e.g. TC, Qi Gong, yoga, or acupuncture) or physical therapy programs for knee OA within the past 3 months.
  • Severe medical limitations (i.e., dementia, symptomatic heart or vascular disease, or recent stroke) precluding full participation.
  • Medical/neurologic or other systemic diseases affecting the musculoskeletal systems (i.e. polio/Parkinson's/multiple sclerosis, etc. in addition to cerebral vascular accident or stroke) and diabetes with peripheral neuropathy affecting their sensory/balance.
  • Intra-articular steroid injection or reconstructive surgery on most severely affected knee in the past three months.
  • Intra-articular hyaluronic acid injections on most severely affected knee in the past six months.
  • Inability to walk without an assistive device.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Texas Tech University Health Sciences Center

    Lubbock, Texas, 79430

Other trials in United States

About this study

Official title: Tai Chi for Pain Management of Knee Osteoarthritis

This study is to determine how 8-week Tai Chi intervention alters plasma endocannabinoid and its receptors in monocytes/marcrophages, plasma oxylipinds, plasma brain-derived neurotrophic factor, brain white matter connectivity/efficiency, and functional/clinical outcomes in women with knee OA.

Read the detailed description

Knee osteoarthritis (OA) is one of the five leading causes of disability. Previous studies have shown that a mind-body moderate-intensity Tai Chi (TC) exercise (8-24 weeks) reduced pain and improved physical function for knee OA, when compared to a waiting list, attention control, usual physical activity, or physical therapy. However, TC's mechanisms of action regarding improvement of one's clinical condition and its functional outcomes in individuals with knee OA are poorly understood. This study is to determine how 8-week TC intervention alters plasma endocannabinoid and its receptors in monocytes/marcrophages, plasma oxylipinds, plasma brain-derived neurotrophic factor, brain white matter connectivity/efficiency, and functional/clinical outcomes in women with knee OA.

Being tested
Tai chi exercise
Medical subject headings
Osteoarthritis, Knee

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Tai chi exerciseBehavioural

    24-form Yang style Tai Chi (60 min/session, 3 sessions/week) for 8 weeks

Study groups in NCT04046003
Study groupRoleWhat they receive
Tai Chi interventionExperimental24-form Yang style Tai Chi
Receives: Behavioral: Tai chi exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. endocannabinoid

    plasma endocannabinoid levels

    Measured: Changes from bseline endocannabinoid levels at 8 weeks

  2. oxylipins

    plasma oxylipins levels

    Measured: Changes from baseline oxylipins levels at 8 weeks

Secondary outcomes (7)
  1. endocannabinoid receptors expression

    expression of endocannabinoids receptors on peripheral blood mononuclear cells using flow cytometry. Collect venous blood into evacuated tube containing lithium heparin and pour into a Leucosep tube prepared with Ficoll-Paque. Following sequential centrifugation steps, peripheral blood mononuclear cells will be collected and incubate with endotoxin (e.g. LPS or PMA) for 24 hours (Venable 2016). After incubation, PBMC will be collected and stained with cannabinoid receptors (CB1R and CB2R) and markers for monocytes/macrophages (CD14, etc).

    Measured: Changes from baseline the affinity of endocannabinoid receptor expression at 8 weeks

  2. BDNF

    plasma brain-derived neurotrophic factor levels using ELISA

    Measured: Changes from baseline BDNF levels at 8 weeks

  3. white matter connectivity/efficiency of various fiber tracts in the brain

    We will follow the protocol of Vachon-Presseau et al. 2006 to collect DTI data. DTI images will be acquired using echo planar imaging (72 x 2-mm thick axial slices; matrix size = 128 x 128; field of view = 256 x 256mm2, resulting in a voxel size of 2 x 2 x 2mm). Images will have an isotropic distribution along 60 directions using a b-value of 1000s/mm2. For each set of diffusion-weighted data, eight volumes with no diffusion weighting will be acquired at equidistant points throughout the acquisition.

    Measured: Change from baselinewhite matter connectivity/efficiency of various fiber tracts in the brain at 8 weeks

  4. pain sensitivity

    We will use quantitative sensory test including windup to assess pain sensitivity in the most painful knee of subject

    Measured: Change from baseline pain sensitivity scale at 8 weeks

  5. Pain assessment

    We will use Brief Pain Inventory (questionnaire) for pain assessment.

    Measured: Change from baseline pain scale at 8 weeks

  6. physical function

    We will use WOAMC questionnaire for physical function assessment

    Measured: Changes from baseline WOMAC results at 8 weeks

  7. Quality of life assessment

    Quality of life status will be assessed with the Medical Outcomes Study 36-item short form Health Survey (SF-36, version 2), which consists of eight dimensions of health (physical function, bodily pain, general health, vitality, mental health, social function, and role of physical and emotional health) in the conduct of daily activity characteristics will be assessed with self-report SF-36 questionnaires related to self-rated health, depression, anxiety and sleep quality.

    Measured: Changes from baseline SF-36 results at 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Aug 2019
  2. Study start1 Sep 2019
  3. Primary completion30 Jun 2024
  4. Study completion31 Aug 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
24-form Yang style Tai Chi (60 min/session, 3 sessions/week) for 8 weeks.
Masking
None (open label)
Enrolment
33 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04046003
Sponsor's protocol ID
Tai Chi for Knee OA pain
Status last verified
Mar 2025
First submitted
26 Jul 2019
Last updated
28 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Shen CL, Newman JW, Elmassry MM, Borkowski K, Chyu MC, Kahathuduwa C, Neugebauer V, Watkins BA. Tai Chi exercise reduces circulating levels of inflammatory oxylipins in postmenopausal women with knee osteoarthritis: results from a pilot study. Front Med (Lausanne). 2023 Aug 16;10:1210170. doi: 10.3389/fmed.2023.1210170. eCollection 2023.

    PubMed 37654656

Questions about this trial

What is this clinical trial studying?

A study testing Tai chi exercise in people with Knee Osteoarthritis and Mind-body Exercise, run by Texas Tech University Health Sciences Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

endocannabinoid (time frame: Changes from bseline endocannabinoid levels at 8 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04046003, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in